𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

✍ Scribed by Schmitz, M; Temme, A; Senner, V; Ebner, R; Schwind, S; Stevanovic, S; Wehner, R; Schackert, G; Schackert, H K; Fussel, M

Book ID
109999119
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
327 KB
Volume
96
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Identification of HLA-A2- and A24-restri
Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy
✍ Ryo Ueda; Kozo Ohkusu-Tsukada; Noemi Fusaki; Akio Soeda; Takeshi Kawase; Yutaka πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 399 KB

## Abstract Malignant gliomas are the most aggressive human primary brain tumors and are currently incurable. Immunotherapies have the potential to target glioma and glioma stem cells (GSCs) that are resistant to conventional therapies. We previously identified SOX6 as a human glioma antigen and de

Disialoganglioside GD2 and a novel tumor
Disialoganglioside GD2 and a novel tumor antigen: Potential targets for immunotherapy of desmoplastic small round cell tumor
✍ Modak, Shakeel ;Gerald, William ;Cheung, Nai-Kong V. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

## Abstract ## Background Desmoplastic small round cell tumor (DSRCT) is an aggressive and often misdiagnosed neoplasm of children and young adults. It is chemotherapy‐sensitive, yet patients often relapse off therapy because of residual microscopic disease at distant sites: peritoneum, liver, lym